Conversations across Verpora’s NHS payer network have identified a significant disconnect: more than 80% of current pharmaceutical industry engagement is perceived as poor, with a failure to demonstrate value.
In this webinar, Verpora’s Omar Ali and Paul Dermody are joined by NHS decision-makers Yousaf Ahmed and David Thorne for a candid discussion about why engagement is falling short, what good engagement looks like to the NHS, and what pharma needs to do differently.
Register Now
2:00PM (London) – Wednesday 31 October
Attendance is complimentary for eligible pharmaceutical manufacturer personnel and healthcare professionals.
What’s changing?
NHS England’s central function is reducing, with fewer people operating at a national level.
Local NHS services are transitioning towards neighbourhood health models.
The Single National Formulary is being rolled out to local medicines optimisation teams.
So what do these changes mean for pharma’s engagement strategy when it comes to securing and supporting access to medicines?
The changing NHS also requires a broader understanding of who influences access. The webinar will explore why “payer” increasingly means anyone involved in the local implementation of national guidance, from formulary and commissioning pharmacists to clinical teams, networks, alliances, transformation and governance functions.
By joining us for this fireside chat you will walk away with:
an understanding of the changing NHS landscape faced by experts involved in making decisions about local access to pharmaceutical products
NHS decision-makers’ candid reflections on current engagementswith pharma manufacturers
how engagement must change to ensure they remain relevant and valuable to both parties
Format & Duration
45-minute live panel discussion with NHS payers and decision makers
15-minutes audience Q&A
Who is this webinar for?
This online masterclass is open exclusively to personnel from pharmaceutical manufacturers, and NHS healthcare professionals working within…
| National and Local Market Access and Pricing leaders | Market access Managers, Regional Access Managers |
| Healthcare Partnership Managers, NHS Partnership Leads | Key Account Managers, Local access managers, Integrated Healthcare Managers |
| National and Regional sales leaders | Brand Team members |
Register Now
2:00PM (London) – Wednesday 31 October
Attendance is complimentary for eligible pharmaceutical manufacturer personnel and healthcare professionals.
Speakers
Omar Ali BSc(Hons)Pharm DipClinPharm MRPharmS ACPP
Head of Payers, Verpora | LinkedIn
Drawing on more than 30 years of experience from the payer perspective, including a decade at the internationally recognised HTA body NICE, Omar supports Verpora’s clients in navigating payer expectations and developing practical access strategies.
Paul Dermody
Head of Learning and Development, Verpora | LinkedIn
With more than 36 years of senior leadership experience, Paul specialises in senior leadership development, strategic thinking, and management training. He is particularly focused on supporting teams in complex, high-stakes environments, helping leaders think clearly, act decisively, and bring others with them.
Yousaf Ahmed
NHS Chief Pharmacist and Director of Medicines and Pharmacy,
NHS Thames Valley ICB | LinkedIn
Yousaf brings senior leadership experience across the NHS and corporate sectors, with expertise spanning clinical care, governance, digital healthcare and international pharmacy. He currently holds a range of board, advisory and education roles.
David Thorne
NHS Transformation Director, Well Up North PCN | LinkedIn
45 years experience of UK health services, and 10 years employed in pharma and medtech market access roles and involved in some of the most successful product launches seen in the UK, with an impressive track record of delivery in the NHS and pharmaceutical industry. A leading UK authority on clinical commissioning, market access and applied heath economics.